Wall Street Lifts Targets on Five Below, Ulta Beauty and Nature's Sunshine Ahead of Key Earnings Reports

Barclays raised Five Below's target to $211 from $193 but the stock trades at $219.82 (above the new target); Canaccord lifted Ulta Beauty to $799 from $674 and Nature’s Sunshine to $29 from $22. Five Below reported Q3 comps +14.3% and raised guidance; Ulta's Q3 revenue $2.858B beat estimates with comps +6.3% and a new UK/IE footprint via Space NK; Nature’s Sunshine saw Q3 revenue beat, digital sales +52% and APAC growth >30%. All three have near-term catalysts (NATR reports today, ULTA Mar 12, FIVE Mar 18) and elevated multiples (Ulta fwd P/E ~23x, Five Below ~32x, NATR fwd P/E ~24x; NATR EV/EBITDA ~8.9x).

Analysis

The analyst moves amplify a bifurcated market signal: large-cap/brand-led beauty is being re-rated for durable share gains and capital return optionality, while value-oriented specialty retail is trading on execution momentum that may be more cyclically sensitive. For Ulta, the marginal return on inventory and cash deployed into buybacks/international rollout is likely to drive outsized EPS delta over 12–24 months, creating convexity versus consensus. For Five Below, the path to incremental EBIT is more exposed to unit-level margin pressure from import-cost volatility and tariff passthrough, meaning upside is concentrated in same-store sales rather than margin expansion.

Nature’s Sunshine represents a liquidity/volatility trade where digital penetration and APAC mix can deliver outsized operating leverage, but limited float makes implied volatility both a funding source and a risk: moves will be sharp on beats or misses. Second-order winners include Asian contract manufacturers and freight/logistics providers if APAC-driven growth sustains, while domestic private-label suppliers to mass beauty could lose share if prestige assortments continue to rotate through new formats. Across the trio, consensus is pricing differentiated risk premia — growth multiple compression is the primary lever to reverse recent moves, not small revenue misses.

Near-term catalysts cluster around upcoming results and initial fiscal guidance; price action will be driven by guidance cadence and margin cadence rather than one-quarter sales beats. Tail risks include an abrupt tariff announcement, a consumer credit shock that re-weights spend toward discount channels, or a visible slowdown in digital CAC efficiency that compresses smaller-cap margin expansion. Position sizing should reflect asymmetric liquidity and earnings event risk: largest sizing where buyback optionality and franchise durability create multi-year optionality, smallest where float and headline risk can induce >25% intraday moves.

Key Decisions for Investors

• Long ULTA (core position, 6–12 month horizon): buy shares or buy-call 6–9 month call spreads to capture international expansion and buyback-driven EPS upside. Size as a 2–4% portfolio position with a stop at -15% and a target of +25–40% on fundamental re-rating.
• Tactical hedge on FIVE (near-term, earnings window): buy 6–8 week put spreads ~8–12% OTM to protect against tariff/gross-margin disappointment; cost is limited premium, payoff asymmetric if same-store sales miss. Risk: limited to premium paid; reward: potential 15–30% downside capture on headline shock.
• Volatility-enabled exposure to NATR (event-driven, short horizon + optional long leg): initiate a small long position funded by selling near-term calls or buy a calendar call spread to exploit expected post-earnings IV re-pricing. Target 2:1 upside/downside; keep exposure below 1% portfolio given low float.
• Relative-value pair (3–6 months): long ULTA / short a large prestige peer with weaker omnichannel metrics to neutralize macro beta. Use 1:0.7 size ratio to limit gross exposure; objective is to capture share-shift and execution premium while hedging discretionary risk.